Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A user is creating a homemade topical solution by dissolving finasteride pills in Kirkland minoxidil to reduce side effects from oral finasteride. They report slowed hair loss and some regrowth but are unsure if the results are due to minoxidil or finasteride.

2-deoxy-D-ribose, a sugar molecule, is found to be 80%-90% as effective as Minoxidil in promoting hair growth, showing potential for alopecia treatment. Concerns include high cost, lack of human studies, and possible side effects like diarrhea and nausea.

The conversation discusses GT20029, a drug in Phase II trials that targets androgen receptors with minimal systemic effects, and TDM-105795, a growth stimulant with a different mechanism than minoxidil that may revive papilla stem cells. Both are potential new treatments for hair loss.

The user is considering liposomal minoxidil due to non-response and side effects from other treatments. They are exploring tretinoin with topical minoxidil as an alternative.

RU58841's potential toxicity to cats is uncertain, similar to minoxidil. Caution is advised to prevent accidental exposure to pets.

Dutasteride is used for hair regrowth, with some users experiencing side effects like reduced libido, changes in semen consistency, and emotional effects. Some users report positive hair regrowth results, while others experience issues like gynecomastia and fat accumulation.

The user plans to mix Kirkland minoxidil with spironolactone tablets for hair loss. They cannot use finasteride, saw palmetto, or spearmint tea due to side effects like insomnia and low testosterone.

A new extended-release oral minoxidil formulation claims to improve hair growth by maintaining steady blood levels, reducing side effects like hypotension, and potentially benefiting female hair loss. However, it is not considered groundbreaking as it builds on existing minoxidil treatments, and its effectiveness compared to current doses is debated.

Stopping antihistamines may resolve neurological side effects when using finasteride. Users experienced muscle aches, headaches, and lethargy when combining the two.

HMI 115 is being discussed as a potential hair loss treatment, with skepticism due to past disappointments like cosmeRNA, brezula, and pyrilutamide. The user is questioning if they should be hopeful for new developments in the next six years.

A dermatologist prescribed oral minoxidil, finasteride, and spironolactone, suggesting minoxidil and finasteride as the most effective combination, but with potential side effects. Another user recommended minoxidil (both topical and oral) and spironolactone for female hair loss, advising against finasteride.

The user is concerned about starting a compounded tablet with 1.1mg finasteride and 3mg minoxidil due to potential side effects. Others suggest starting with the prescribed dose and adjusting if side effects occur, noting that 3mg is within a common range.

A user discusses using a mixed solution with minoxidil 2%, hydrocortisone butyrate, and estrone in the morning, and considering adding 5% minoxidil at night. They also use Restax softgel but avoid finasteride.

Kintor's 1% Pyrilutamide will be released in October/November. The user cannot tolerate finasteride.

The user experienced side effects from daily finasteride and reduced the dosage to 0.25mg twice a week while continuing minoxidil. They are considering topical anti-androgens but are concerned about application difficulties and potential side effects.

The user experienced initial success with topical finasteride 0.025% and melatonin but noticed rapid hair thinning after three months. They are considering switching to a higher dose of topical finasteride or oral finasteride, as advised by others, while being cautious about potential side effects.

A user with AGA uses topical spironolactone 2% due to side effects from the oral form and is concerned about its use during conception and breastfeeding. They seek alternatives to prevent AGA relapse while planning pregnancy and after childbirth.

The user has been using a daily capsule containing 1mg finasteride and 2.5mg minoxidil for 11 months, with noticeable regrowth on the crown but minimal improvement on the hairline. They experienced no significant side effects and plan to continue the treatment long-term.

The conversation is about finding a reliable source for oral minoxidil and finasteride in the EU after a previous supplier stopped offering them. Suggestions include Pharmacy Tristaina in Andorra and bgpharma, with users sharing their experiences and dosages.

Alfatradiol is discussed as a weak 5ARI and estrogen, not as effective as minoxidil, RU58841, or CB-03-01, but a safe alternative for those who can't use finasteride. Users express frustration over the lack of strong FDA-approved topical antiandrogens for hair loss.

The conversation discusses whether to take oral minoxidil in a split dose or a single dose at night. Users suggest that taking a single 10mg dose at night is simpler, while splitting may help minimize side effects.

Combining stemoxydine with minoxidil and finasteride in one solution is generally considered fine, though some believe stemoxydine is ineffective. Mixing them may dilute minoxidil and finasteride slightly, but it shouldn't be a problem.

Tazarotene's potential to enhance Minoxidil conversion, similar to Tretinoin, is questioned. Users discuss the lack of information and seek further details.

A user decided to drink minoxidil solution due to difficulties with topical application and cost, taking 0.28ml daily. Others shared their experiences with similar methods, noting effectiveness and minimal side effects, while some expressed concerns about safety and self-medication.

A user shared progress pictures after using topical minoxidil twice daily and oral finasteride daily for three months, reporting no side effects and improvement after two months. The user experienced high libido, no significant shedding, and occasional brain fog linked to social media use.

The user has been using finasteride for four years and topical minoxidil with microneedling for a year but has not seen significant results in slowing hair loss. They are considering trying dutasteride despite concerns about its intensity, and others suggest trying oral minoxidil or combining treatments for better results.

A user experienced surprising results with 1 mg finasteride after five months, noticing reduced shedding and increased hair thickness. They plan to start minoxidil and dermastamping, reporting no significant side effects on libido.

A 24-year-old shares progress on hair regrowth after 3 months using 2.5mg oral minoxidil, 0.5mg dutasteride, and scalp injections of dutasteride, minoxidil, and vitamins every two weeks. They are uncertain if the improvement is due to actual regrowth or just longer hair.

Clascoterone won't be available in the US until 2028, with EU filings planned for 2027. It's considered an alternative for those who experience side effects from standard treatments like finasteride and dutasteride.

Concerns about a potential ban on finasteride and dutasteride due to side effects, with users advocating for continued access and informed choice. Alternative treatments like pyrilutamide are also mentioned.